beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->6)]-alpha-D-Glcp

Term ID

CHEBI:146490

Synonyms

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3R,4S,5R,6S)-3,5,6-trihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
beta-D-gluco-hexopyranosyl-(1->3)-[beta-D-gluco-hexopyranosyl-(1->6)]-alpha-D-gluco-hexopyranose
beta-D-glucopyranosyl-(1->3)-[beta-D-glucopyranosyl-(1->6)]-alpha-D-glucopyranose
Glc(b1-3)[Glc(b1-6)]a-Glc

Definition

A α-D-Glcp-(1→4)-[α-D-Glcp-(1→6)]-D-Glcp which has α- configuration at the anomeric carbon of the non-terminal glucopyranose ring.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->6)]-alpha-D-Glcp

Phenotype where environments contain beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->6)]-alpha-D-Glcp

Phenotype modified by environments containing beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->6)]-alpha-D-Glcp

Phenotype affecting beta-D-Glcp-(1->3)-[beta-D-Glcp-(1->6)]-alpha-D-Glcp

Human Disease Model